Intubated
[용어속성] Term
Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients
Emergency Medicine
[키워드] 60-day survival
acute respiratory distress
acute respiratory syndrome
analyzed
ARDS
cause
coronavirus
coronavirus disease
COVID-19
COVID-19 patient
Critically ill
death
defined
ECMO
enrolled
extracorporeal membrane oxygenation
female
First wave
Germany
ICU
ICU resources
IMPROVE
intensive care
Intracerebral hemorrhage
Intubated
median age
moderate
multi-organ failure
outcome
outcomes
Patient
per day
polymerase chain
renal replacement therapy
reported
required
resource
Respiratory failure
RRT
SARS-CoV-2
suffered
survival
survived
syndrome
the patient
Treatment
university hospital
was performed
[DOI] 10.7759/cureus.13210 PMC 바로가기 [Article Type] Emergency Medicine
[DOI] 10.7759/cureus.13210 PMC 바로가기 [Article Type] Emergency Medicine
D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis
Medicine
[키워드] Administered
Analysis
anticoagulation
appear
benefit
bleeding event
control group
COVID-19
COVID-19 disease
Critical
D-dimer
D-dimer level
D-dimer levels
D-dimer-driven anticoagulation
Effect
Escalation
groups
hypercoagulability
ICU patient
ICUs
Infection
intensive care unit
Intubated
intubated patient
intubated patients
kidney dysfunction
Mortality
organ dysfunction
organ function
outcome
overall mortality
paper
Patient
patients
patients treated
patients with COVID-19
performed
protocol
provide
Safe
serum
serum creatinine
Severe COVID-19 Infection
shown
significantly lower
standard thromboprophylaxis
stratified
subject
survival
thromboembolic complication
Thromboprophylaxis
thrombotic complication
Thrombotic complications
transfusion
treated
university
with COVID-19
[DOI] 10.3389/fmed.2021.631335 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.631335 PMC 바로가기 [Article Type] Medicine
Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients
중대한 COVID-19 폐렴의 치료에 Tocilizumab: 기계 환기 환자에 대한 후향적 코호트 연구
Article
[키워드] 95% CI
age
Clinical outcome
co-morbidities
co-morbidity
cohorts
controls
Corticosteroids
COVID-19
Critical
Cytokine release syndrome
demographic characteristics
determine
evaluate
Hospitalization
increased risk
Infection
inflammatory markers
intensive care
Intubated
intubation
Invasive mechanical ventilation
Logistic regression analysis
Mechanical
mechanical ventilation
mechanically ventilated patient
Mortality
nasopharyngeal
New York
Odds ratio
Organ failure
Patient
patients with COVID-19
PCR
Pneumonia
polymerase chain
reduction in mortality
required
retrospective cohort study
severity
significantly lower
SOFA
Tocilizumab
treated
Treatment
university
with COVID-19
[DOI] 10.1016/j.ijid.2020.12.021 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ijid.2020.12.021 PMC 바로가기 [Article Type] Article
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19
Observational Study
[키워드] assessment
Biomarker
Blood
Contact
COVID-19
COVID-19 patient
COVID-19 patients
Deceased
Decreased
disease
disease severity
donors
expression
Glucose
GLUT1
heart
Infection
Intubated
investigated
involved
moderate
Myocardium
NHE1.
non-infected
other respiratory infection
outcome
Patient
patients with COVID-19
patients with moderate
PCR
performed
predict
presenting
progression
quantitative assessment
quantitative PCR
respiratory infection
respiratory infections
RNA
RNA expression
SARS-COV-2 infection
severe disease
significantly
sodium
stratified
the disease
up-regulated
ventricular
was performed
Whole blood
with COVID-19
[DOI] 10.1002/ehf2.13063 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1002/ehf2.13063 PMC 바로가기 [Article Type] Observational Study
Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19
COVID-19로 입원한 대규모 환자 집단에서 HIV 혈청형 및 바이러스 억제에 의한 임상 결과 및 염증 표지자
Article
[키워드] Acute kidney injury
adjusted
adjusted hazard ratio
AKI
black
both groups
C-reactive protein
Care
CD4 count
CD4 counts
CD4 T-cell
cell counts
clinical
Clinical outcome
clinical outcomes
competing
conducted
COVID-19
death
detectable
died
examined
ferritin
ferritin level
ferritin levels
finding
group
health system
Hispanic
HIV
Hospitalization
Hospitalized
IL-6
immune
immune marker
In-hospital
In-hospital death
in-hospital mortality
increased risk
Inflammatory
Intubated
intubation
intubation rate
Intubation rates
intubations
Limited
marker
MOST
Most patients
neutrophil
neutrophil counts
Patient
PCR-positive patient
PLWH
retrospective cohort study
risk
SARS-CoV-2
serostatus
significantly lower
suppressed
suppression
USA
Viral
Viral load
with COVID-19
with HIV
[DOI] 10.1097/QAI.0000000000002578 PMC 바로가기 [Article Type] Article
[DOI] 10.1097/QAI.0000000000002578 PMC 바로가기 [Article Type] Article
A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City
Observational Study
[키워드] 95% CI
95% confidence interval
acute respiratory syndrome
age
Care
complications
conducted
coronavirus
coronavirus disease
COVID-19
COVID-19 symptom
CSF
determine
Diabetic
diagnose
diagnosed
discharge
discharge home
disorder
Encephalopathy
hazard ratio
hospital
Hospitalized
hypertensive
in-hospital mortality
increased risk
Injury
Intubated
intubation
laboratory-confirmed SARS-CoV-2 infection
likelihood
male
median
medications
Mortality
multicenter
neurologic
neurologic disorder
neurologic disorders
New York City
Older
Organ failure
outcomes
Patient
patients with COVID-19
Prevalence
Prospective
recorded
reverse transcriptase PCR
SARS-CoV-2
SARS-COV-2 infection
Seizure
Sex
SOFA
SOFA scores
specimen
stroke
systemic illness
was recorded
[DOI] 10.1212/WNL.0000000000010979 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1212/WNL.0000000000010979 PMC 바로가기 [Article Type] Observational Study
Evaluation of patient characteristics, management and outcomes for COVID-19 at district hospitals in the Western Cape, South Africa: descriptive observational study
Observational Study
[키워드] 95% CI
ACCIDENT &
age
assessment
Asthma
Cape
Care
Characteristics
Chronic kidney disease
chronic obstructive
Clinical management
clinical outcomes
clinical picture
Comorbidities
Comorbidity
comparable
COVID-19
cross-sectional
demographics
discharged home
disease
District
emergency medicine
Factor
females
HIV
hospital
hospitals
hypertension
increased mortality
Increasing
Intubated
IQR
Laboratory
Lung disease
majority
male
management
median
Mild
moderate
Mortality
MOST
Most patient
outcome
oxygen
Patient
patients with COVID-19
Physicians
positive
presenting symptoms
primary care
pulmonary
pulmonary disease
reported
respiratory infections
risk factor
Rural health
secondary outcome
significantly
Source
South
South Africa
supported
Test
tested
transferred
treated
Treatment
Tuberculosis
type 2 diabete
Ventilated
[DOI] 10.1136/bmjopen-2020-047016 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1136/bmjopen-2020-047016 PMC 바로가기 [Article Type] Observational Study
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research
바이오 뱅킹에 대한 체계적인 접근 방식을 사용하고 COVID-19 연구를 발전시키기 위한 임상 및 유전 데이터 분석
Clinical Trial
Published on
Journal: European Journal of Human Genetics [Category] MERS, SARS, 변종, 유전자 메커니즘, 임상, 진단,
Journal: European Journal of Human Genetics [Category] MERS, SARS, 변종, 유전자 메커니즘, 임상, 진단,
[키워드] adaptive
affected
approach
Asymptomatic
biobanking
biospecimen
biospecimens
BiPAP
chemosensors
Clinical data
clotting system
collected
COVID-19
COVID-19 research
COVID-19 severity
CPAP
CPAP-biPAP
cytokine
cytokine storm type
Data collection
DNA
FIVE
GCB
GCGDR
GCPR
GEN-COVID Biobank
GEN-COVID Multicenter Study
GEN-COVID Patient Registry
genetic data
genetic parameter
genetic parameters
Genetics research
heart
Hierarchical clustering analysis
high-density
hospitalized patient
hospitalized patients
Hyposmia
identifying multi-organ
Immunity
include
Infection
innate or adaptive immunity
Intubated
Italian
kidney
leukocytes
liver
Liver damage
Mild
moderate
multicenter study
multisystemic
network
organs/system
organs/systems
pancreas
pancreatic
patients
pauci- or asymptomatic
plasma
respiratory
Respiratory Support
Sample
SARS-CoV-2 positive individual
serum
severe multisystemic failure
SNP genotyping
subject
susceptibility
thromboembolic
treated
viral infection
Whole blood
whole-exome sequencing
[DOI] 10.1038/s41431-020-00793-7 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1038/s41431-020-00793-7 PMC 바로가기 [Article Type] Clinical Trial
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
COVID-19 폐렴 환자에서 호흡 악화 예방을 위한 BIO101의 효능 및 안전성 테스트(COVA 연구): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
20-hydroxyecdysone
absence
accumulation
ACE2
Activation
acute respiratory distress
acute respiratory distress syndrome
adaptive
addition
administration
Airway Pressure
all-cause mortality
ALT
Alter
amenorrhea
Analysis
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
Angiotensin converting enzyme-2
Anti-inflammatory
anticipated
approved
ARDS
arterial oxygen saturation
AST
Asymptomatic
balance
baseline
being
Belgium
beneficiary
Bilirubin
BIO101
Biomarker
Biomarkers
birth control
blinded
Brazil
breath
Cardiomyopathy
Care
Caregivers
caused
clinical development
Clinical finding
Clinical findings
clinical picture
co-morbidities
co-morbidity
collected
Compliance
condition
condom
conducted
confirmation
Consumption
Continuous
Continuous Positive Airway Pressure
Contraception
contraceptive method
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infection symptom
COVID-19 infection symptoms
COVID-19 patient
COVID-19 patients
criteria
criterion
daily dose
Day
death
defined
Department
Deterioration
develop
diabetes
diagnosis of COVID-19
dialysis
discharge
discharged
disease
dissemination
DMC
dose
double-blind
downstream
ECMO
Effect
effective
Efficacy
Efficacy and safety
EGFR
element
eligible participant
Eligible participants
endotracheal tube
Endpoint
enzyme
etonogestrel
EudraCT
European
evaluate
event
Evidence
evidence of
exclusion criteria
expected
exploratory
extracorporeal membrane oxygenation
female
female participants
Final
FiO2
Flow
following
form
France
French
functional
Gault
Gender
healthcare
healthcare facility
heart disease
High-flow oxygen
higher risk
hospital
hospital care
Hospitalization
Hospitalized
hypersensitivity
hypertension
IBM
ICF
Imbalance
include
Inclusion
independent
indication
Infection
Inflammation
informed consent form
injection
Interim analyses
interim analysis
Intervention
intrauterine device
Intubated
Invasive mechanical ventilation
IWRS system
lactating
limit
Liver function
liver function tests
male participants
marker
Mas receptor
maximum
measure
mechanical ventilation
medical intervention
medication
medications
minute
moderate
morbidities
Moribund
Mortality
mouth
Multiorgan dysfunction
muscles
myocarditis
negative urine pregnancy test
Non-COVID-19
number
obesity
objective
observation
offer
Older
oral contraceptive
outcome
outlined
oxygen
Part
participant
partner
pathway
Pathways
patients with COVID-19
patients with SARS-CoV-2
PCR
performed
Pericarditis
Physical examination
Placebo
placebo-controlled
Pneumonia
positive airway pressure
post-intervention
post-menopausal
powder
pregnancy test
pressure
primary endpoint
proof
proportion
Proportion of participant
protocol
public health
randomised
randomised controlled trial
randomization
RAS
reached
receive
receiving
receptor
recruited
recruitment
Registered
renal
renal disease
renal insufficiency
Renin
renin angiotensin system
renin-angiotensin system
reproduction
required
resource
respiratory
Respiratory distress syndrome
Respiratory failure
Respiratory function
respiratory symptoms
restored
risk
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
SARS-CoV2 spike protein
second
secondary
secondary endpoint
security
severe pneumonia
Shock
Social Security
specimen
Sperm
Spike protein
SpO2
Statistical power
status
Sterilization
Stratification
stratified
study medication
Study protocol
supplementary material
survival
suspicion
Symptom
syndrome
tachypnea
target population
tested
Testing
the primary endpoint
therapeutic
therapeutic option
tissue
Tolerability
Total
total bilirubin
Treatment
treatment arm
treatment period
Triage
Trial
Trial registration
ULN
Urine
USA
variety
vasectomy
Version
Viral load
water
website
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter